SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4
- Konstantinos Tzelepis
- , Etienne De Braekeleer
- , Demetrios Aspris
- , Isaia Barbieri
- , M. S. Vijayabaskar
- , Wen Hsin Liu
- , Malgorzata Gozdecka
- , Emmanouil Metzakopian
- , Hamish D. Toop
- , Monika Dudek
- , Samuel C. Robson
- , Francisco Hermida-Prado
- , Yu Hsuen Yang
- , Roya Babaei-Jadidi
- , Dimitrios A. Garyfallos
- , Hannes Ponstingl
- , Joao M.L. Dias
- , Paolo Gallipoli
- , Michael Seiler
- , Silvia Buonamici
- Wellcome Sanger Institute
- University of Cambridge
- Karaiskakio Foundation
- University of Cambridge
- Helmholtz Zentrum München German Research Center for Environmental Health
- University of New South Wales
- Exonate Ltd
- University of Portsmouth
- Cambridge University Hospitals NHS Foundation Trust
- Eisai Inc.
- German Cancer Research Center
- Cellzome GmbH
- European Bioinformatics Institute
- Ludwig-Maximilians-Universität München
- The University of Nottingham Medical School
Research output: Contribution to journal › Article › peer-review
68
Scopus
citations